PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33370365-0	2020	Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.	Fluorodeoxyglucose F18	47-54	epidermal growth factor receptor	Homo sapiens	109-113	
33370365-1	2020	BACKGROUND: To investigate the survival prognostic value of the radiomic features of 18F-FDG PET in patients who had EGFR (epidermal growth factor receptor) mutated lung adenocarcinoma and received targeted TKI (tyrosine kinase inhibitor) treatment.	Fluorodeoxyglucose F18	85-92	epidermal growth factor receptor	Homo sapiens	117-121	
33370365-1	2020	BACKGROUND: To investigate the survival prognostic value of the radiomic features of 18F-FDG PET in patients who had EGFR (epidermal growth factor receptor) mutated lung adenocarcinoma and received targeted TKI (tyrosine kinase inhibitor) treatment.	Fluorodeoxyglucose F18	85-92	epidermal growth factor receptor	Homo sapiens	123-155